164 related articles for article (PubMed ID: 16429254)
21. One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength.
Ominsky MS; Stolina M; Li X; Corbin TJ; Asuncion FJ; Barrero M; Niu QT; Dwyer D; Adamu S; Warmington KS; Grisanti M; Tan HL; Ke HZ; Simonet WS; Kostenuik PJ
J Bone Miner Res; 2009 Jul; 24(7):1234-46. PubMed ID: 19257823
[TBL] [Abstract][Full Text] [Related]
22. Osteoprotegerin ameliorates sciatic nerve crush induced bone loss.
Bateman TA; Dunstan CR; Lacey DL; Ferguson VL; Ayers RA; Simske SJ
J Orthop Res; 2001 Jul; 19(4):518-23. PubMed ID: 11518255
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.
Schett G; Stolina M; Dwyer D; Zack D; Uderhardt S; Krönke G; Kostenuik P; Feige U
Arthritis Rheum; 2009 Sep; 60(9):2644-54. PubMed ID: 19714640
[TBL] [Abstract][Full Text] [Related]
24. Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis.
Boettger MK; Weber K; Schmidt M; Gajda M; Bräuer R; Schaible HG
Pain; 2009 Sep; 145(1-2):142-50. PubMed ID: 19570610
[TBL] [Abstract][Full Text] [Related]
25. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
26. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
[TBL] [Abstract][Full Text] [Related]
27. Histomorphometry of periarticular bone in rheumatoid arthritis.
Kröger H; Arnala I; Rehnberg V; Hämäläinen M; Alhava E
Ann Chir Gynaecol; 1994; 83(1):56-62. PubMed ID: 8053640
[TBL] [Abstract][Full Text] [Related]
28. RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis.
Verdrengh M; Bokarewa M; Ohlsson C; Stolina M; Tarkowski A
Bone; 2010 Mar; 46(3):752-8. PubMed ID: 19879986
[TBL] [Abstract][Full Text] [Related]
29. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
[TBL] [Abstract][Full Text] [Related]
30. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
[TBL] [Abstract][Full Text] [Related]
31. Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant Mice.
Bolon B; Grisanti M; Villasenor K; Morony S; Feige U; Simonet WS
Vet Pathol; 2015 Sep; 52(5):873-82. PubMed ID: 26018435
[TBL] [Abstract][Full Text] [Related]
32. Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
Zwerina J; Tuerk B; Redlich K; Smolen JS; Schett G
Arthritis Res Ther; 2006; 8(1):R22. PubMed ID: 16507121
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target.
Boettger MK; Hensellek S; Richter F; Gajda M; Stöckigt R; von Banchet GS; Bräuer R; Schaible HG
Arthritis Rheum; 2008 Aug; 58(8):2368-78. PubMed ID: 18668541
[TBL] [Abstract][Full Text] [Related]
34. Sequential alterations of periarticular structures in antigen-induced arthritis in mice. Histological observations on fibrous capsule, ligaments, bone and muscles, using whole joint sections.
Kruijsen MW; van den Berg WB; van de Putte LB
Br J Exp Pathol; 1983 Jun; 64(3):298-305. PubMed ID: 6882678
[TBL] [Abstract][Full Text] [Related]
35. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
Koufany M; Chappard D; Netter P; Bastien C; Weryha G; Jouzeau JY; Moulin D
Arthritis Rheum; 2013 Dec; 65(12):3084-95. PubMed ID: 23982996
[TBL] [Abstract][Full Text] [Related]
36. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.
Badger AM; Blake S; Kapadia R; Sarkar S; Levin J; Swift BA; Hoffman SJ; Stroup GB; Miller WH; Gowen M; Lark MW
Arthritis Rheum; 2001 Jan; 44(1):128-37. PubMed ID: 11212150
[TBL] [Abstract][Full Text] [Related]
37. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
[TBL] [Abstract][Full Text] [Related]
38. Juxtaarticular bone loss in experimental inflammatory arthritis.
Bogoch E; Gschwend N; Bogoch B; Rahn B; Perren S
J Orthop Res; 1988; 6(5):648-56. PubMed ID: 3404321
[TBL] [Abstract][Full Text] [Related]
39. Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment.
Bogoch ER; Lee TC; Fornasier VL; Berger SA
J Rheumatol; 2007 Jun; 34(6):1229-40. PubMed ID: 17516617
[TBL] [Abstract][Full Text] [Related]
40. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
